Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 09/15/2017
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mark Albertini MD | None | None | None | None | ✔ |
| Alain Algazi MD | Acerta Pharma Amgen Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Corvus GSK MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Taylor Blessey LLC | None | None | ✔ |
| Robert Andtbacka MD | Amgen Inc. Takara |
Amgen Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Christopher Barker MD | Amgen Inc. Elekta Genentech, Inc. Merck & Co., Inc. |
Pfizer Inc. | None | None | - |
| Christopher Bichakjian MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| William Carson III MD | National Cancer Institute | None | None | None | ✔ |
| Daniel Coit MD, FACS | None | None | None | None | ✔ |
| Alycia Corrigan | None | None | None | None | - |
| Gregory Daniels MD, PhD | Bristol Myers Squibb Eisai Inc. Prometheus Regeneron Viralytics |
None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Dominick DiMaio MD | None | None | None | None | - |
| Anita Engh PhD | None | None | None | None | - |
| Ryan Fields MD | Washington University | None | None | None | ✔ |
| Martin Fleming MD, FACS | None | None | None | None | - |
| Brian Gastman MD | AbbVie, Inc. alkermes Merck & Co., Inc. |
AMD-Serrano | Castle Biosciences Merck & Co., Inc. quest imaging |
None | ✔ |
| Rene Gonzalez MD | Aileron Amgen Inc. Array Pharmaceuticals Boston Biomedical Bristol Myers Squibb California Stem Cell Castle Bioscience Celldex Checkmate Pharma Dynavax Eisai Inc. EMD Serono GSK Hana Biosciences, Inc. Incyte Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Morphotek Inc. Neostem Novartis Pharmaceuticals Corporation Oncosec polynoma Prometheus Reata Roche Laboratories, Inc. Syndax Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Verastem |
Bristol Myers Squibb Castle Bioscience Novartis Pharmaceuticals Corporation |
verastem | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Valerie Guild MBA | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Douglas Johnson MD, MSCI | None | Bristol Myers Squibb Genoptix Incyte Merck & Co., Inc. |
None | None | ✔ |
| Richard Joseph MD | Amgen Inc. Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Syndax X4P |
Bristol Myers Squibb Incyte Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Julie Lange MD, ScM | None | None | None | None | ✔ |
| Kim Margolin MD | altor Amgen Inc. Bristol Myers Squibb checkmate ImaginAb Iovance Merck & Co., Inc. |
ImaginAb Pfizer Inc. |
None | None | ✔ |
| Miguel Materin MD | None | Castle Bioscience Expert witness Trial case |
None | None | - |
| Joan McClure MS | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Sameer Nath MD | None | None | None | None | - |
| Anthony Olszanski MD, RPh | Amgen Inc. Bristol Myers Squibb Eli Lilly and Company EMD Serono Incycte Intensity Therapeutics Kura Kyowa Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb G1 Therapeutics Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Patrick Ott MD, PhD | Armo Biosciences AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Celldex Merck & Co., Inc. |
Alexion Pharmaceuticals, Inc. Celldex Cytomx Genentech, Inc. |
None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Aparna Priyanath Gupta MD | None | None | None | None | - |
| Kumar Rao MD | Regeneron | Castle Bioscience | None | None | - |
| Ramesh Rengan MD, PhD | None | None | None | None | - |
| Merrick Ross MD | None | Amgen Inc. CastleBiosciences GSK Merck & Co., Inc. Provectus Pharmaceuticals |
Amgen Inc. CastleBiosciences Merck & Co., Inc. Provectus Pharmaceuticals |
None | - |
| April Salama MD | AbbVie, Inc. Bristol Myers Squibb Celldex Dynavax Genentech, Inc. Immunocore Merck & Co., Inc. Reata Roche Laboratories, Inc. |
Bristol Myers Squibb Merck & Co., Inc. |
Bristol Myers Squibb | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Joseph Skitzki MD | None | None | None | None | ✔ |
| Jeffrey Sosman MD | None | Array Pharma Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Susan Swetter MD | None | None | None | None | ✔ |
| Kenneth Tanabe MD | National Cancer Institute | Back Bay Life Science Advisors Best Doctors CRICO Department of Defense, CDMRP LEK Consulting UpToDate |
None | Helix12 | ✔ |
| John Thompson MD | Agensys, Inc. Bristol Myers Squibb Celldex Corvus Pharmaceuticals Five Prime Therapeutics Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. Seattle Genetics Trillium |
Celldex | None | None | ✔ |
| Javier Torres-Roca MD | Cvergenx, Inc | None | None | Cvergenx, Inc|Cvergenx,Inc | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Marshall Urist MD | MSLT 2 Trial | None | None | None | ✔ |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | - |